Merck & Co. (MRK)
(Delayed Data from NYSE)
$118.64 USD
+0.35 (0.30%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $118.97 +0.33 (0.28%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 21 - 40 ( 403 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 1224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 12223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended October 20.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 102123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department